LSE:CCH News 3 December 2025

Coca-Cola HBC share price slips after shareholder vote backs Africa deal paperwork

Coca-Cola HBC shares fell 0.2% to 3,918 pence in London after shareholders approved all board proposals tied to its planned acquisition of 75% of Coca-Cola Beverages Africa. Over 98% of votes backed measures enabling flexible share issuance and use of treasury shares. The company aims to close the deal by end-2026, pending regulatory approval. Investors await Feb. 10 results for details on financing and deal timing.

19 January 2026

LSE:CCH

Coca-Cola HBC AG (LON: CCH) Stock on 3 December 2025: Price, Fresh News, and Analyst Outlook

Coca-Cola HBC AG (LON: CCH), one of The Coca-Cola Company’s largest bottling partners and a key player across Europe, Nigeria and an expanding African footprint, is firmly on investors’ radar on 3 December 2025. The stock is reacting to new technical signals, fresh sustainability news and the still‑digesting impact of its multibillion‑dollar African expansion. CCH Group Website+1 Coca-Cola HBC share price today: trading near the upper end of its range As of late morning in London on 3 December 2025, Coca-Cola HBC shares trade around 3,730–3,732p, down modestly on the day and slightly below Tuesday’s close of 3,764p. The intraday

3 December 2025

LSE:CCH·Stock Market

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

7 February 2026

Merck shares closed up 1.8% at $121.93 Friday after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140. Insider filings showed three executives sold shares this week. Merck’s stock ended just below its 52-week high, with about 13 million shares traded.

LSE:CCH News 3 December 2025 - 19 January 2026

Coca-Cola HBC share price slips after shareholder vote backs Africa deal paperwork

Coca-Cola HBC AG (LON: CCH) Stock on 3 December 2025: Price, Fresh News, and Analyst Outlook

Stock Market Today

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

AstraZeneca stock price: What could move AZN next week as earnings loom

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface